PER-005-97已完成未知
COMPARATIVE, DOUBLE-BLIND, RANDOMIZED STUDY TO EVALUATE THE SAFETY TOLERABILITY AND EFFICACY OF L-743,872 VS AMPHOTERICIN B IN THE TREATMENT OF CANDIDA ESOPHAGILITIS INFECTIONS IN ADULTS
MERCK SHARP & DOHME PERU S.R.L.,0 个研究点目标入组 0 人开始时间: 1997年11月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 0（—）
入选标准
- •a) The patient must have been diagnosed with an esophageal candidiasis, documented according to the following criteria:
- •1. Symptoms such as odynophagia (pain when swallowing), dysphagia, feeling of food adherence in the retrostemal area or retrostemal pain.
- •2. Esophagoscopy with photographic documentation of the presence of characteristic mucosal plaques and evaluated prospectively as follows: Grade O = normal esophageal mucosa; Grade Vi = rare and scattered individual protruding plates, each with a size <2 mm; Grade I = scattered plaques with a size> 2 mm that cover less than 50% of the esophageal mucosa; Grade 2 = plates with a size> 2 mm that cover more than 50% of the esophageal mucosa; Grade 3 = confluent plates covering circumferentially more than half of the mucosa; Grade 4 = circumferential plates with narrowing of light despite insufflation.
- •3. Brushing esophageal plate with a wet preparation and staining with PAS to demonstrate the presence of Candida pseudohyphae (one culture was also performed).
- •4. biopsy esophageal lesions (to confirm the findings brushing) with histological evidence of pseudohyphae characteristics of Candida in conventional coloring, and confirmation by staining with silver methenamine, PAS or Giemsa; a crop will also be made.
- •b) Patients must be adults 18 to 65 years old (any sex). Women of childbearing age are eligible ONLY if they have HIV infection and if their doctor has carefully examined the risk / benefit relationship. Before admission to the study, HIV-positive women of childbearing age must undergo a pregnancy test (determination of serum b-HCG) to be negative result; subsequently they must use an adequate contraceptive method defined by the researcher. Oral contraceptives should not be used as the only contraceptive method since the effect of L-743,872 on the efficacy of these drugs has not yet been established. To be admitted to the study, women who are not HIV + must be sterile (surgical sterilization or more than one year after menopause).
- •c) Before the study, the ECG of the patients should be within normal limits. Benign alterations of the ECG will be allowed, according to the investigator´s criteria.
- •d) Before the study, the chest x-ray of the patients should not show signs of active lung disease.
- •e) The values of the following laboratory parameters must be obtained before admission to the study:
- •1. Hematocrit> 30% (men) and> 27% (women)
- •2. White blood cell count> 1000 / ul
- •3. Platelet count> 10,000 / ul
- •4. Creatinine within normal limits.
- •5. Prothrombin time and partial thromboplastin time within normal limits.
- •6. AST (TGO) and ALT (TGP) 7. Alkaline phosphatase <1 V2 times the upper limit of normal
排除标准
- •a. The patient does not meet any of the inclusion criteria.
- •b. History of allergy, hypersensitivity or any adverse reaction to an antifungal of the echinocandin family or amphotericin B.
- •c. Women of childbearing or fertile age who do not suffer from HIV infection, regardless of their marital status. This group includes women who use oral, injectable or mechanical contraceptives, women whose sexual partners have been vasectomized, women who use mechanical barrier contraceptive devices and women who are susceptible to receiving fertilized ovules in vitro or to undergo insemination. artificial.
- •d. Patients in whom treatment with fluconazole or ketoconazole for an anterior esophageal candidiasis has failed.
- •e. Patients with an episode of esophageal candidiasis in the last 30 days.
- •f. Patients with AIDS whose life expectancy is less than 6 months.
- •g. Patients with AIDS and other opportunistic infections.
- •h. Patients with another cause of esophagitis (eg, CMV), in addition to Candida.
- •i. Patients with a history of infection with CMV and with the Mycobacterium avium complex (CMA).
- •j. Patients who can not undergo an esophagoscopy and an esophageal biopsy.
- •k. Patients in whom the esophagoscopy reveals the presence of ulcers.
- •l. Any patient with a diagnosis of cirrhosis or acute or chronic hepatitis of any etiology.
- •m. Participation in any other clinical study involving the administration of a research drug at the time of admission or during the conduct of the study. Previous participation in this study at any time.
- •n. Any concomitant disease that, according to the researcher, could produce confusion in the interpretation of the results of the study or expose the patient to an additional risk due to the administration of study drugs.
研究者
相似试验
已完成
不适用
A clinical trial to study the effect of amino acid infusion on body temperature in patients undergoing knee joint replacement surgery in cold operating room environment.CTRI/2009/091/000972SANT PARMANAND HOSPITA160
招募中
1 期
A clinical trial to compare the effects of two drugs, bupivacaine and ropivacaine in combination with fentanyl in labour pain reliefCTRI/2010/091/000150Sant Parmanand Hospital100
尚未招募
1 期
Haemodynamic derangements during laryngoscopy using different intubating devicesCTRI/2019/09/021176Department of Anesthesiology and Critical Care
尚未招募
Unknown
A randomized, prospective, comparative study to evaluate the efficacy and safety of diced ADM alone use versus combined use of diced ADM and micronized ADM filler for reconstruction of defect areas after breast conserving surgery in breast cancer patientsNeoplasmsKCT0008492Kosin University Gospel Hospital100
进行中（未招募）
1 期
Dermatitis StudyEUCTR2017-001574-42-Outside-EU/EEAGlaxoSmithKline Research & Development Ltd123